James Scibetta
Director/Board Member at MATINAS BIOPHARMA HOLDINGS, INC.
Net worth: 118 292 $ as of 2024-04-29
James Scibetta active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Director/Board Member | 2013-10-31 | - |
| Independent Dir/Board Member | 2013-10-31 | - | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Director/Board Member | 2016-12-31 | - |
| Chief Executive Officer | 2016-12-31 | - | |
ImmuneID, Inc.
 ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Director/Board Member | 2021-09-20 | - |
| Chief Executive Officer | 2021-09-20 | - |
Career history of James Scibetta
Former positions of James Scibetta
| Companies | Position | Start | End |
|---|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Director/Board Member | 2017-04-10 | 2022-06-21 |
| Independent Dir/Board Member | 2017-04-10 | 2022-06-21 | |
| PACIRA BIOSCIENCES, INC. | Director of Finance/CFO | 2008-07-31 | 2016-05-02 |
| President | 2015-10-19 | 2017-06-29 | |
| NEPHROS, INC. | Chairman | 2007-11-15 | 2013-12-30 |
| Independent Dir/Board Member | 2012-05-16 | 2013-12-30 | |
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Director/Board Member | 2000-12-31 | 2008-11-06 |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Director of Finance/CFO | 2006-10-31 | 2007-10-31 |
| MERRIMACK PHARMACEUTICALS, INC. | Director of Finance/CFO | 1998-03-31 | 2006-10-31 |
Training of James Scibetta
| Wake Forest University | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Statistics
International
| United States | 11 |
| Canada | 2 |
Operational
| Director/Board Member | 5 |
| Director of Finance/CFO | 3 |
| Independent Dir/Board Member | 3 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 3 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| NEPHROS, INC. | Health Technology |
| PACIRA BIOSCIENCES, INC. | Health Technology |
| MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
| AQUESTIVE THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Health Technology |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Commercial Services |
- Stock Market
- Insiders
- James Scibetta
- Experience
